Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $46.5000 (8.14%) ($35.5000 - $47.5000) on Fri. Oct. 18, 2013. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 10.36% (three month average) | RSI | 84 | Latest Price | $46.5000(8.14%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 9.4% a day on average for past five trading days. | Weekly Trend | CAPR advances 21.5% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) PEJ(5%) EWP(4%) IWM(4%) XAR(4%) XOP(4%) | Factors Impacting CAPR price | CAPR will decline at least -5.18% in a week (0% probabilities). IGOV(-2%) EMHY(-2%) REMX(-1%) GLD(-1%) EWY(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -5.18% (StdDev 10.36%) | Hourly BBV | 0 () | Intraday Trend | 8.1% | | | |
|
5 Day Moving Average | $38.5(20.78%) | 10 Day Moving Average | $34.13(36.24%) | 20 Day Moving Average | $30.68(51.56%) | To recent high | 0% | To recent low | 220.7% | Market Cap | $916m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |